UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000471
Receipt number R000000564
Scientific Title A confirmatory trial of BK-PIFA in healthy volunteers.
Date of disclosure of the study information 2006/09/04
Last modified on 2006/12/08 12:19:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A confirmatory trial of BK-PIFA in healthy volunteers.

Acronym

BK-PIFA/002

Scientific Title

A confirmatory trial of BK-PIFA in healthy volunteers.

Scientific Title:Acronym

BK-PIFA/002

Region

Japan


Condition

Condition

Japanese healthy volunteers

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess BK-PIFA immunogencity and safety by subcutaneous vaccination in healthy volunteers.

Basic objectives2

Others

Basic objectives -Others

Dose-response

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

1. Levels of HI antibody titer to H5 antigen
2. Levels of neutralization antibody titer to H5N1Influenza Virus
3. To assess AE/ADR ,and type/frequency/duration of side reaction by from after Day 0 to post examination day

Key secondary outcomes

Evaluation of antibody reactivity of 5microgram and 15microgram


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Vaccine

Interventions/Control_1

H group ( 15microgram group)

Interventions/Control_2

L group ( 5microgram group)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Implement as follows,
Written informed consent.
Abide by compliance ongoing rules.
Have screening examination predetermind the protocol.
Subjects who can report self condition etc.

Key exclusion criteria

1. Defined history of H5N1 avian flu ( gived subjects )
2. Previously H5 avian flu vaccinated ( gived subjects )
3. Subjects who has induced anaphylaxis by substance of foods and drugs.
4. Any cllinically significant history of heart, vasculature, blood systems, respiratory, liver, kidney, digestive, neuropsychiatric disorder.
5. History of Guillain- Barre Syndrome and Acute-disseminated-encephalomyelitis.
6. Participation in any clinical trial within 4months.
7. Previous treatment for livevaccine within 27days, or inactivated vaccine( without influenza vaccine HA vaccine)/toxoid within 6days.
8. Previously influenza vaccine HA vaccine within 4months.
9. History of blood transfusion or gamma-globulin preparations within 3months, or massive dose therapy of gamma-globulin preparations (greater or equal 200 mg/kg ) within 6months.
10. Pregnant and probably pregnant subjects.
11. Others judged as being inappropriate for the subjects of the study by investigators.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitoshi Kamiya

Organization

National Hospital Organization Mie National Hospital

Division name

Honorary Director

Zip code


Address

357 Oozatokubota-chou, Tsu-shi, Mie-ken, 514-0125 Japan

TEL

059-232-2531

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

National Hospital Organization Mie National Hospital

Division name

Office of Clinical Trials Coordinating investigator /JMACCT

Zip code


Address

17Fl. Bunkyo Green Court Center Office, 2-28-8 Honkomagome, Bunkyo-ku, Tokyo 113-0021, Japan

TEL

03-5319-3781

Homepage URL


Email

BK-PIFA@jmacct.med.or.jp


Sponsor or person

Institute

National Hospital Organization Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Medical Association

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

The Research Foundation for Microbial Diseases of Osaka University

Name of secondary funder(s)

The Research Foundation for Microbial Diseases of Osaka University


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 09 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 08 Month 18 Day

Date of IRB


Anticipated trial start date

2006 Year 09 Month 01 Day

Last follow-up date

2006 Year 10 Month 01 Day

Date of closure to data entry

2006 Year 11 Month 01 Day

Date trial data considered complete

2006 Year 11 Month 01 Day

Date analysis concluded

2006 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 08 Month 15 Day

Last modified on

2006 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000564


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name